Author Archives for Michael Jacques

Inventiva announces trading resumption of its ordinary shares on Euronext Paris

July 10, 2020 2:35 pm Published by Comments Off on Inventiva announces trading resumption of its ordinary shares on Euronext Paris

Daix (France), July 10, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (“NASH”), mucopolysaccharidoses (“MPS”) and other diseases with significant unmet medical need, announced the trading resumption of its ordinary shares on Euronext in Paris (“Euronext Paris”) as...